Clinical Trial Update: Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial of brexpiprazole in adults with major depressive disorder and anxiety was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Major Depressive Disorder (MDD) | Phase 4 | Status: WITHDRAWN